These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Gillis AM, Verma A, Talajic M, Nattel S, Dorian P, CCS Atrial Fibrillation Guidelines Committee. Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862 [Abstract] [Full Text] [Related]
3. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Joseph AP, Ward MR. Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228 [Abstract] [Full Text] [Related]
12. Hybrid therapy of atrial fibrillation. Santini M, Pignalberi C, Ricci R, Calò L. Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814 [Abstract] [Full Text] [Related]
13. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study]. Niu F, Huang CX, Jiang H, Yang B, Guo WL, Chen YX, Jin CR, Liu ZM. Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):121-3. PubMed ID: 16620720 [Abstract] [Full Text] [Related]
17. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial. Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Piccione G, Di Giovanni N, Colletti A, Pensabene O, Lisi F, Vasquez L, Grammatico A, Boriani G, PITAGORA Study Investigators. Am Heart J; 2008 Jan 05; 155(1):100-7, 107.e1. PubMed ID: 18082498 [Abstract] [Full Text] [Related]